SECONDARY ENUCLEATION IN RETINOBLASTOMA
While aiming for global salvage in the management of retinoblastoma, caution should be exercised for patients >36 months of age, with a treatment duration of >12 months and a requirement of >9 cycles of systemic chemotherapy. When secondary enucleation is planned, care providers should be warned against deferring it beyond 1 month.
Authors
- Purva Agarwal (ORCID: https://orcid.org/0009-0001-5687-8256)
- Swathi Kaliki (ORCID: https://orcid.org/0000-0002-0800-9961)
- Komal Bakal
- Vijitha S. Vempuluru (ORCID: https://orcid.org/0000-0002-1859-6629)
- Gurkiran Kaur (ORCID: https://orcid.org/0000-0002-4522-7271)
Institutions
- L V Prasad Eye Institute (IN)
Publication Details
- Journal
- Retina
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1097/iae.0000000000004504
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00